Marker Therapeutics, Inc.
MRKR
$1.20
$0.065.26%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.93M | 1.17M | 1.24M | 1.06M | 257.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.93M | 1.17M | 1.24M | 1.06M | 257.60K |
| Cost of Revenue | 3.47M | 2.34M | 2.58M | 2.62M | 2.05M |
| Gross Profit | -1.55M | -1.17M | -1.33M | -1.56M | -1.79M |
| SG&A Expenses | 854.70K | 1.14M | 1.22M | 1.38M | 1.41M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.33M | 3.48M | 3.79M | 3.99M | 3.46M |
| Operating Income | -2.40M | -2.31M | -2.55M | -2.94M | -3.20M |
| Income Before Tax | -2.31M | -2.19M | -2.39M | -2.74M | -2.98M |
| Income Tax Expenses | -- | -- | -- | 3.70K | -- |
| Earnings from Continuing Operations | -2.31M | -2.19M | -2.39M | -2.74M | -2.98M |
| Earnings from Discontinued Operations | -- | -- | -- | -62.90K | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.31M | -2.19M | -2.39M | -2.80M | -2.98M |
| EBIT | -2.40M | -2.31M | -2.55M | -2.94M | -3.20M |
| EBITDA | -- | -- | -- | -2.24M | -2.50M |
| EPS Basic | -0.26 | -0.25 | -0.27 | -0.32 | -0.34 |
| Normalized Basic EPS | -0.16 | -0.15 | -0.17 | -0.19 | -0.21 |
| EPS Diluted | -0.26 | -0.25 | -0.27 | -0.32 | -0.34 |
| Normalized Diluted EPS | -0.16 | -0.15 | -0.17 | -0.19 | -0.21 |
| Average Basic Shares Outstanding | 8.92M | 8.92M | 8.90M | 8.89M | 8.83M |
| Average Diluted Shares Outstanding | 8.92M | 8.92M | 8.90M | 8.89M | 8.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
